{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:51:43Z","timestamp":1776145903858,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s13730-019-00400-9","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T14:05:05Z","timestamp":1557497105000},"page":"239-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pathological findings of progressive renal involvement in a patient with TAFRO syndrome"],"prefix":"10.1007","volume":"8","author":[{"given":"Hirotaka","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-9355","authenticated-orcid":false,"given":"Kenichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokutaro","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Eiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro James","family":"Kazama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"400_CR1","first-page":"320","volume":"51","author":"K Takai","year":"2010","unstructured":"Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Jpn J Clin Hematol. 2010;51:320\u20135.","journal-title":"Jpn J Clin Hematol"},{"key":"400_CR2","doi-asserted-by":"publisher","first-page":"e8216","DOI":"10.1097\/MD.0000000000008216","volume":"96","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Tsujimoto H, Yamamoto K, et al. Clinicopathological features of progressive renal involvement in TAFRO syndrome: a case report and literature review. Medicine. 2017;96:e8216.","journal-title":"Medicine."},{"key":"400_CR3","doi-asserted-by":"publisher","first-page":"e6271","DOI":"10.1097\/MD.0000000000006271","volume":"96","author":"FF Jose","year":"2017","unstructured":"Jose FF, Kerbauy LN, Perini GF, et al. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: the first case report in Latin America. Medicine. 2017;96:e6271.","journal-title":"Medicine."},{"key":"400_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3109\/14397595.2015.1059982","volume":"27","author":"M Kawashima","year":"2017","unstructured":"Kawashima M, Usui T, Okada H, et al. TAFRO syndrome: 2 cases and review of the literature. Mod Rheumatol. 2017;27:1093\u20137.","journal-title":"Mod Rheumatol."},{"key":"400_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ndt\/gfq427","volume":"26","author":"K El Karoui","year":"2011","unstructured":"El Karoui K, Vuiblet V, Dion D, et al. Renal involvement in Castleman disease. Nephrol Dial Transplant. 2011;26:599\u2013609.","journal-title":"Nephrol Dial Transplant"},{"key":"400_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhabitation and renal thrombotic microangiopathy. N Eng J Med. 2008;358:1129\u201336.","journal-title":"N Eng J Med."},{"key":"400_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12185-016-1979-1","volume":"103","author":"Y Masaki","year":"2016","unstructured":"Masaki Y, Kawabata H, Takai K, et al. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016;103:686\u201392.","journal-title":"Int J Hematol"},{"key":"400_CR8","doi-asserted-by":"publisher","first-page":"e11057","DOI":"10.1097\/MD.0000000000011057","volume":"97","author":"Y Furuto","year":"2018","unstructured":"Furuto Y, Hashimoto H, Horiuti H, et al. Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor. Medicine. 2018;97:e11057.","journal-title":"Medicine."},{"key":"400_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3109\/14397595.2015.1120389","volume":"28","author":"K Sakai","year":"2018","unstructured":"Sakai K, Maeda T, Kuriyama A, et al. TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol. 2018;28:564\u20139.","journal-title":"Mod Rheumatol"},{"key":"400_CR10","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.2169\/internalmedicine.8522-16","volume":"56","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Shimizu T, Toyama T, et al. Successful treatment of TAFRO syndrome with tocilizumab, prednisone, and cyclophosphamide. Intern Med. 2017;56:2205\u201311.","journal-title":"Intern Med"},{"key":"400_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12185-016-1978-2","volume":"103","author":"S Fujiwara","year":"2016","unstructured":"Fujiwara S, Mochinaga H, Nakata H, et al. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids. Int J Hematol. 2016;103:718\u201323.","journal-title":"Int J Hematol"},{"key":"400_CR12","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.2169\/internalmedicine.55.6455","volume":"55","author":"E Ohya","year":"2015","unstructured":"Ohya E, Mizutani M, Sakaguchi H, et al. Diffuse large B-cell lymphoma during corticosteroid therapy for TAFRO syndrome. Intern Med. 2015;55:2861\u20137.","journal-title":"Intern Med"},{"key":"400_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ajh.24242","volume":"91","author":"N Iwaki","year":"2016","unstructured":"Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016;91:220\u20136.","journal-title":"Am J Hematol"},{"key":"400_CR14","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","volume":"65","author":"BF Schrijvers","year":"2004","unstructured":"Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65:2003\u201317.","journal-title":"Kidney Int"},{"key":"400_CR15","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1046\/j.1523-1755.2001.00935.x","volume":"60","author":"S Suga","year":"2001","unstructured":"Suga S, Kim YG, Joly A, et al. Vascular endotherial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int. 2001;60:1297\u2013308.","journal-title":"Kidney Int"},{"key":"400_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s13730-018-0319-0","volume":"7","author":"S Noda-Narita","year":"2018","unstructured":"Noda-Narita S, Sumida K, Hoshino A, et al. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report. CEN Case Rep. 2018;7:162\u20138.","journal-title":"CEN Case Rep."},{"key":"400_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13730-018-0338-x","volume":"7","author":"T Ozeki","year":"2018","unstructured":"Ozeki T, Tsuji M, Yamamoto J, et al. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome. CEN Case Rep. 2018;7:243\u20137.","journal-title":"CEN Case Rep"},{"key":"400_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.prp.2018.12.025","volume":"215","author":"N Kurose","year":"2019","unstructured":"Kurose N, Mizutani K, Kumagai M, et al. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome. Pathol Res Pract. 2019;215:410\u20133.","journal-title":"Pathol Res Pract"},{"key":"400_CR19","first-page":"284","volume":"43","author":"N Matsumura","year":"1992","unstructured":"Matsumura N. Distribution of interleukin-6 in human proliferative glomerulonephritides. J Nara Med. 1992;43:284\u201396.","journal-title":"J Nara Med."}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-019-00400-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00400-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T10:52:49Z","timestamp":1589885569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-019-00400-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1007\/s13730-019-00400-9","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"3 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interests affecting the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient in this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}